Seneca Biopharma Inc
SNCA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$60.04
3516.8% upside
Current Fair Value
3516.8% upsideUndervalued by 3516.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $-44.42 |
| Beta | - |
| Outstanding Shares | 366,239 |
Return
| Return on Equity | -205.47% |
|---|---|
| Return on Assets | -155.68% |
| Return on Invested Capital | -206.96% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Seneca Biopharma Inc
CEO: I. Richard Garr